Rare disease rally

Why 5AM co-led a $37M series A for rare disease newco Rallybio

While 5AM Ventures has typically backed platform plays in the rare disease space, the firm is looking to newco Rallybio LLC to build a portfolio out of one-off rare disease candidates sourced from academia and big pharma.

Rallybio, launched by

Read the full 404 word article

How to gain access

Continue reading with a
two-week free trial.